Investigator-initiated clinical trial to investigate the safety and efficacy of intravenous vagal nerve stimulation catheter for bradycardia in patients with supraventricular tachyarrhythmia

Sakamoto Kazuo0 个研究点目标入组 20 人开始时间: 2023年9月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients aged 18 years or older at the time of obtaining consent
•2) Patients with supraventricular tachyarrhythmia who undergo catheter ablation
•3) Patients who have been fully informed, understood and given free written consent by the investigator or sub-investigator of the study
•4) Patients with no cardiac dysfunction (left ventricular ejection fraction more than 50%) at level 1-1

•1) Patients with anomaly of the superior vena cava
•2) Patients with uncontrolled gastric and duodenal ulcers
•3) Patients with implanted pacemaker (including leadless pacemaker), ICD (including S-ICD) and CRT
•4) Patients with a temporary pacemaker inserted
•5) Patients with contraindications to contrast media or severe allergy to contrast media
•6) Patients with any kind of metal allergy
•7) Patients with active bleeding
•8) Patients with NYHA class IV
•9) Patients with severe haemodynamic compromise, such as cardiogenic shock
•10) Patients who are pregnant or potentially pregnant, or who wish to become pregnant during participation in the study
•11) Patients participating in another clinical trial within 3 months of treatment
•12) Patients who are judged by the investigator or sub-investigator to be unsuitable for this clinical trial.

发起方

Sakamoto Kazuo